From Wikipedia, the free encyclopedia
|Chemical and physical data|
|Molar mass||342.442 g·mol−1|
|3D model (JSmol)|
BIM-018 is a synthetic cannabinoid that is the benzimidazole analog of JWH-018. It is presumed to be a potent agonist of the CB2 receptor and has been sold online as a designer drug.
Related benzimidazole derivatives have been reported to be highly selective agonists for the CB2 receptor.
- ^ "BIM-018". Cayman Chemical. Retrieved 24 July 2015.
- ^ Pagé D, Balaux E, Boisvert L, Liu Z, Milburn C, Tremblay M, et al. (July 2008). "Novel benzimidazole derivatives as selective CB2 agonists". Bioorganic & Medicinal Chemistry Letters. 18 (13): 3695–700. doi:10.1016/j.bmcl.2008.05.073. PMID 18522867.
This cannabinoid related article is a stub. You can help Wikipedia by expanding it.
Retrieved from "https://en.wikipedia.org/w/index.php?title=BIM-018&oldid=1082421737"